- Home
- STRO vs FRST Comparison
STRO vs FRST Comparison
Compare STRO & FRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- FRST
- Stock Information
- Founded
- STRO 2003
- FRST 2004
- Country
- STRO United States
- FRST United States
- Employees
- STRO N/A
- FRST N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- FRST Major Banks
- Sector
- STRO Health Care
- FRST Finance
- Exchange
- STRO Nasdaq
- FRST Nasdaq
- Market Cap
- STRO 172.8M
- FRST 290.5M
- IPO Year
- STRO 2018
- FRST 2006
- Fundamental
- Price
- STRO $1.94
- FRST $11.87
- Analyst Decision
- STRO Strong Buy
- FRST Buy
- Analyst Count
- STRO 7
- FRST 1
- Target Price
- STRO $12.14
- FRST $14.00
- AVG Volume (30 Days)
- STRO 1.4M
- FRST 85.6K
- Earning Date
- STRO 11-13-2024
- FRST 01-23-2025
- Dividend Yield
- STRO N/A
- FRST 3.40%
- EPS Growth
- STRO N/A
- FRST N/A
- EPS
- STRO N/A
- FRST N/A
- Revenue
- STRO $160,955,000.00
- FRST $104,308,000.00
- Revenue This Year
- STRO N/A
- FRST N/A
- Revenue Next Year
- STRO N/A
- FRST $12.45
- P/E Ratio
- STRO N/A
- FRST N/A
- Revenue Growth
- STRO 230.90
- FRST N/A
- 52 Week Low
- STRO $1.70
- FRST $9.52
- 52 Week High
- STRO $6.13
- FRST $13.69
- Technical
- Relative Strength Index (RSI)
- STRO 28.52
- FRST 40.26
- Support Level
- STRO $1.70
- FRST $11.62
- Resistance Level
- STRO $1.93
- FRST $12.17
- Average True Range (ATR)
- STRO 0.20
- FRST 0.29
- MACD
- STRO -0.01
- FRST -0.09
- Stochastic Oscillator
- STRO 12.60
- FRST 25.21
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About FRST Primis Financial Corp.
Primis Financial Corp is the bank holding company for Primis Bank, providing financial services to individuals and small and medium-sized businesses. Primis Bank offers a wide range of commercial banking services, it focuses on making loans secured majorly by commercial real estate and other types of secured and unsecured commercial loans to small and medium-sized businesses in a number of industries, as well as loans to individuals for a variety of purposes. Primis Bank offers a broad range of deposit products, including checking (NOW), savings, money market accounts and certificates of deposit.